Categories Earnings, U.S. Markets News

Calendar: Earnings of Walgreens, GameStop, Constellation Brands on queue

Walgreens Boots Alliance, GameStop, Constellation Brands, and more earnings are scheduled for the week between April 1 and 5. Check out what to expect from the major earnings reports next week.

Walgreens Boots Alliance (WBA) will announce second-quarter earnings on Tuesday before the bell. Analysts expect earnings to rise 0.60% to $1.74 per share and revenue to increase 4.80% to $34.62 billion. The results will be benefited by comparable pharmacy sales in the US while same-store sales in the UK is likely to decline as Brexit created a weak retail environment. Amazon’s (AMZN) venture into the drug retail space has pressured the existing players.

Lamb Weston Holdings Inc. (LW) will post Q3 results on Tuesday. Analysts project the company to report earnings of $0.82 per share on revenue of $895.93 million. The bottom line will be hurt by rising input costs as well as higher costs and expenses while the top line will be benefited by favorable mix, pricing actions, and Global and Retail segments growth. However, the limited time offers innovations are likely to benefit the company that could fuel growth and market share gains.

Entertainment and dining venues operator Dave & Buster’s Entertainment (PLAY) will announce Q4 earnings on Tuesday after the bell. Earnings are expected to increase 3.30% to $0.63 per share and revenue is likely to increase 6% to $323.29 million. The results will be benefited by higher revenue across its segments. For fiscal 2019, Dave & Buster’s expects high single-digit growth in revenue and mid-to-high single-digit growth in EBITDA.

Image for representation only (Courtesy: Pexels from Pixabay)

Video game retailer GameStop Corp. (GME) is set to post fourth-quarter results on Tuesday. Analysts project earnings to fall 21.80% to $1.58 per share as underperformance of certain titles, weakness in pre-owned and recent sales promotions will hurt the bottom line. Revenue is predicted to decline by 6.40% to $3.28 billion due to sales decline across all the key business segments. The results will also be hurt by low customer turnout and the rising popularity of online gaming.

Signet Jewelers (SIG) will report Q4 earnings on Wednesday before the bell. Analysts see a profit of $3.82 per share on revenue of $2.14 billion. The diamond jewelry retailer’s results will be hurt by unfavorable impact related to the outsourcing of credit, unfavorable banner mix, higher advertising, higher incentive compensation expense, and restructuring charges.

Acuity Brands Inc. (AYI) could post Q2 results on Wednesday. Earnings are anticipated to fall by 4.20% to $1.81 per share while revenue is likely to rise by 5.60% to $878.96 million. The bottom line is likely to be hurt by higher costs and expenses while the top line will be benefited by growth in sales volume and favorable impacts from acquisitions. The company’s efforts to expand its customer base as well as the roll-out of new products and solutions could be behind the sales growth.

As Constellation Brands Inc. (STZ) announces Q4 results on Thursday before the bell, analysts expect earnings of $1.73 per share on revenue of $1.73 billion. The bottom line will be hurt by a loss from unconsolidated investments and a decline in the fair value of Canopy investments recognized. The top line will be benefited by the strong portfolio performance and market share gains from the beer division as well as strong shipment volume growth in the wine and spirits division.

 

Follow our Google News edition to get the latest stock market, earnings and financial news at your fingertips.

Most Popular

United Parcel Service (UPS) seems on track to regain lost strength

Cargo giant United Parcel Service, Inc. (NYSE: UPS) ended fiscal 2023 on a weak note, reporting lower revenues and profit for the fourth quarter. The company experienced a slowdown post-pandemic

IPO Alert: What to look for when Boundless Bio goes public

Boundless Bio is preparing to debut on the Nasdaq stock market this week, and become the latest addition to the list of biotech firms that have launched IPOs this year.

Nike (NKE) bets on innovation and partnerships to return to high growth

Sneaker giant Nike, Inc. (NYSE: NKE) has been going through a rough patch for some time, with sales coming under pressure from weak demand and rising competition. Post-pandemic, the company

Add Comment
Loading...
Cancel
Viewing Highlight
Loading...
Highlight
Close
Top